Liraglutide for HIV-associated Neurocognitive Disorder

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Temple University
Study ID
NCT02743598
Phase
PHASE4
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This study will test the effect of liraglutide on cognitive function in HIV-infected overweight or obese subjects with type 2 diabetes.

Key Dates

Start date
Sep 30, 2016
Status verified
Jul 2022
Primary completion
Jun 1, 2018
Completion
Sep 30, 2018

Study Design

Enrollment
4 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Liraglutide

Primary Outcome Measure

Neurocognitive performance- change in global cognitive scores on a standard neuropsychological profile [ Time Frame: 6 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Cherie VazPhiladelphiaPennsylvania19140-

Find similar trials in Philadelphia, PA

By condition
HIVObesity / overweight
By specialty
Infectious diseaseEndocrinologyMetabolic healthWeight loss
By research site
Cherie Vaz· Philadelphia, PA

Related Studies